Brief: Hemcheck Sweden Q3 Operating Revenue Rises To SEK 434,672
Nov 19 (Reuters) - Hemcheck Sweden AB HEMC.ST :
* Q3 OPERATING REVENUE SEK 434,672 VERSUS SEK 110,718 YEAR
AGO
* Q3 PRE TAX PROFIT SEK 3.0 MILLION VERSUS SEK 2.6 MILLION
YEAR
AGO
Source text for Eikon: ID:nWkrDBvl2
Further company coverage: HEMC.ST
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Bio Vitos Pharma AB
See all newsAdvisory: Alerts on Bio Vitos Pharma withdrawn
Brief: Bio Vitos Pharma Q4 Operating Revenue Falls To SEK 0.3 Mln
Brief: Bio Vitos Reaches Settlement With Norvolt AS, Norvolt Capital AS
Brief: Bio Vitos Pharma Appoints Sven Rohmann As Acting CEO
Brief: Bio Vitos Pharma Q3 Loss After Financial Items SEK 3.0 Mln